Done sou Salè H1B

Akèy › Anplwayè › 4D Molecular Therapeutics, Inc.

4D Molecular Therapeutics, Inc.: Salè H-1B ak pajon

4D Molecular Therapeutics, Inc. depoze 5 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 5. Medyèn salè yo ofri a: $135,200.

Demann (LCA)5
Certifye5
Adrès anplwayèEmeryville, CA
Anplwayè H-1B depannNon
Salè medyan ofri$135,200
Mwatye salè yo$130,000–$152,506
10yèm–90yèm pousantaj$130,000–$156,727

Èske 4D Molecular Therapeutics, Inc. pajone visa H-1B?

4D Molecular Therapeutics, Inc. depoze 5 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou May 7, 2025. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.

Salè pa tit travay

Tit travayLCASalè medyan
Scientist, Biomarkers1$130,000
Sr. Manager, R&D Informatics1$152,506
Sr. Validation & Compliance Associate1$130,000
Scientist, Molecular and Cell Biology1$135,200
Manager, Manufacturing1$159,541

Aplikasyon pa ane fiskal

Ane fiskalLCASalè medyan
FY20231$130,000
FY20243$135,200
FY20251$159,541

Nivo salè prevanlan

Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.

Kote travay yo ye

Okipasyon

Dènye aplikasyon yo

Tit travaySalè bazKoteSoumètDat kòmansmanEstati
Manager, Manufacturing$159,541Emeryville, CAMay 7, 2025Sep 15, 2025Certifye
Scientist, Molecular and Cell Biology$135,200
Nivo II
Emeryville, CAMay 6, 2024Oct 1, 2024Certifye
Sr. Manager, R&D Informatics$152,506–$170,000
Nivo IV
Emeryville, CAMar 4, 2024Mar 6, 2024Certifye
Sr. Validation & Compliance Associate$130,000–$150,000
Nivo III
Emeryville, CAMar 4, 2024Mar 13, 2024Certifye
Scientist, Biomarkers$130,000–$135,000
Nivo III
Emeryville, CADec 9, 2022Jan 12, 2023Certifye

Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).